Edition:
United States

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

15.73USD
14 Dec 2018
Change (% chg)

$-0.09 (-0.57%)
Prev Close
$15.82
Open
$15.76
Day's High
$16.13
Day's Low
$15.49
Volume
153,847
Avg. Vol
230,959
52-wk High
$35.99
52-wk Low
$15.49

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Perry Karsen

63 2017 Independent Chairman of the Board

John Leonard

60 2018 President, Chief Executive Officer, Director

Glenn Goddard

48 2018 Chief Financial Officer, Executive Vice President

Jose Rivera

52 2017 Executive Vice President, General Counsel

Jesse Goodman

66 2018 Director